Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 2,970 shares at $76.90 ($228K) on 2023-06-13, disclosed to the SEC on 2023-06-14.
Scheduled sale ($228k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.90 | 1,485 | $114K | 50.0% |
| 2 | $76.90 | 1,485 | $114K | 50.0% |
| Total | $76.90 avg | 2,970 | $228K | 100% |
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |